Overexpression of cathepsin B and urokinase plasminogen activator is associated with increased risk of recurrence and metastasis in patients with chondrosarcoma
Open Access
- 1 September 2000
- Vol. 89 (5) , 995-1003
- https://doi.org/10.1002/1097-0142(20000901)89:5<995::aid-cncr8>3.0.co;2-8
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Altered p53 is associated with aggressive behavior of chondrosarcomaCancer, 1998
- Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3Biochemical Journal, 1998
- Association between Ratio of Matrix Metalloproteinase-1 to Tissue Inhibitor of Metalloproteinase-1 and Local Recurrence, Metastasis, and Survival in Human Chondrosarcoma*Journal of Bone and Joint Surgery, 1998
- Bone cancersCancer, 1995
- Production of Matrix Metalloproteinases and a Metalloproteinase Inhibitor by Swarm Rat ChondrosarcomaBiochemical and Biophysical Research Communications, 1994
- Increase of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1) in plasma after thrombolytic therapy of patients with myocardial infarction. A randomised, placebo-controlled studyFibrinolysis, 1992
- The diagnosis and grading of chondrosarcoma of bone a combined cytologic and histologic approachCancer, 1980
- Chondrosarcoma: A clinicopathologic and statistical analysisCancer, 1980
- Prognostic factors in chondrosarcoma of bone.A clinicopathologic analysis with emphasis on histologic gradingCancer, 1977